Index RUT
P/E -
EPS (ttm) -3.83
Insider Own 7.94%
Shs Outstand 24.61M
Perf Week -6.04%
Market Cap 3.32B
Forward P/E 16.40
EPS next Y 8.23
Insider Trans -2.71%
Shs Float 22.66M
Perf Month -1.32%
Income -93.69M
PEG -
EPS next Q 1.50
Inst Own 101.00%
Short Float 4.27%
Perf Quarter -17.80%
Sales 2.42B
P/S 1.37
EPS this Y 6.98%
Inst Trans -1.40%
Short Ratio 3.11
Perf Half Y -21.54%
Book/sh 80.76
P/B 1.67
EPS next Y 23.65%
ROA -2.21%
Short Interest 0.97M
Perf Year 26.96%
Cash/sh 11.77
P/C 11.46
EPS next 5Y 14.10%
ROE -4.62%
52W Range 100.91 - 196.26
Perf YTD -13.05%
Dividend Est. -
P/FCF 25.25
EPS past 5Y -
ROI -2.66%
52W High -31.25%
Beta 0.89
Dividend TTM -
Quick Ratio 1.50
Sales past 5Y 16.29%
Gross Margin 35.00%
52W Low 33.70%
ATR (14) 6.76
Dividend Ex-Date -
Current Ratio 2.57
EPS Y/Y TTM -56.19%
Oper. Margin 4.86%
RSI (14) 45.27
Volatility 3.80% 4.53%
Employees 15000
Debt/Eq 0.81
Sales Y/Y TTM 7.19%
Profit Margin -3.88%
Recom 1.50
Target Price 188.25
Option/Short Yes / Yes
LT Debt/Eq 0.77
EPS Q/Q 61.30%
Payout -
Rel Volume 0.70
Prev Close 138.00
Sales Surprise 5.15%
EPS Surprise 34.37%
Sales Q/Q 6.72%
Earnings May 08 AMC
Avg Volume 311.02K
Price 134.92
SMA20 -2.17%
SMA50 -4.05%
SMA200 -14.63%
Trades
Volume 218,866
Change -2.23%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-12-25 Upgrade
Raymond James
Outperform → Strong Buy
$205 → $197
Dec-11-24 Upgrade
Jefferies
Hold → Buy
$200
Oct-14-24 Initiated
Jefferies
Hold
$183
Jun-21-24 Initiated
Needham
Hold
Jun-17-24 Upgrade
Raymond James
Mkt Perform → Outperform
$135
Nov-08-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Mar-18-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$206
Aug-08-19 Downgrade
Raymond James
Strong Buy → Outperform
Oct-17-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Jun-20-17 Downgrade
Sidoti
Buy → Neutral
Mar-11-16 Initiated
Gabelli & Co
Buy
$128
Nov-06-15 Reiterated
ROTH Capital
Buy
$124 → $130
Aug-11-15 Reiterated
ROTH Capital
Buy
$102 → $124
May-06-15 Reiterated
ROTH Capital
Buy
$96 → $102
Feb-10-15 Reiterated
ROTH Capital
Buy
$82 → $96
Nov-11-14 Upgrade
ROTH Capital
Neutral → Buy
$56 → $82
May-09-13 Downgrade
The Benchmark Company
Buy → Hold
Sep-27-12 Reiterated
The Benchmark Company
Buy
$60 → $69
Apr-12-12 Initiated
The Benchmark Company
Buy
$60
Show Previous Ratings
May-09-25 11:15AM
03:38AM
12:36AM
May-08-25 06:45PM
05:41PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
May-07-25 09:54AM
04:55AM
May-01-25 08:30AM
Apr-29-25 05:59AM
Apr-24-25 08:30AM
Apr-10-25 01:20PM
(Morningstar Research) -8.35%
Apr-09-25 06:33AM
Apr-08-25 12:04PM
Apr-07-25 08:00AM
05:03AM
Loading…
Mar-25-25 05:03AM
Mar-24-25 08:30AM
Mar-21-25 07:04AM
Mar-07-25 08:40AM
Mar-06-25 08:02AM
Mar-03-25 07:19PM
Feb-28-25 07:28AM
(Thomson Reuters StreetEvents)
02:33AM
Feb-27-25 09:06PM
06:20PM
05:19PM
(Associated Press Finance)
05:10PM
04:05PM
Feb-26-25 08:03AM
07:22AM
04:04AM
Loading…
Feb-14-25 04:04AM
04:01AM
Feb-13-25 04:05PM
04:05PM
04:02AM
04:01AM
Jan-03-25 08:30AM
Nov-13-24 02:16AM
02:04AM
Nov-12-24 05:45PM
04:38PM
(Associated Press Finance)
04:05PM
04:05PM
Nov-11-24 07:05AM
Nov-06-24 08:30AM
Oct-28-24 10:01AM
08:30AM
Oct-18-24 12:10PM
Oct-07-24 06:37AM
Sep-19-24 12:20PM
Sep-17-24 09:15AM
Sep-16-24 10:34AM
Sep-10-24 06:11AM
Aug-23-24 09:15AM
Aug-22-24 09:40AM
Aug-21-24 08:30AM
Aug-12-24 07:13AM
Aug-09-24 06:28AM
Aug-08-24 07:45PM
(Morningstar Research) +24.27%
Aug-07-24 06:15PM
05:08PM
(Associated Press Finance)
04:05PM
Jul-26-24 06:40PM
Jul-24-24 08:30AM
Jul-23-24 07:42AM
Jun-17-24 09:00AM
May-31-24 02:44AM
May-08-24 02:43PM
11:00AM
06:27AM
03:44AM
May-07-24 09:01PM
05:55PM
05:55PM
04:52PM
(Associated Press Finance)
04:05PM
Apr-23-24 08:30AM
Mar-13-24 08:30AM
Mar-05-24 11:41PM
Mar-01-24 05:15PM
Feb-28-24 07:48PM
(Morningstar Research) +5.31%
09:49AM
09:36AM
(Thomson Reuters StreetEvents)
Feb-27-24 06:20PM
05:21PM
(Associated Press Finance)
04:36PM
04:05PM
Feb-20-24 10:00AM
Feb-14-24 11:18PM
Feb-13-24 09:02AM
08:30AM
Nov-27-23 06:28PM
Nov-07-23 10:36AM
Nov-06-23 11:37PM
05:23PM
05:17PM
(Associated Press Finance)
04:05PM
Oct-27-23 09:06PM
Oct-23-23 08:30AM
Sep-25-23 08:40AM
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
FINNEY ELISHA W Director May 19 '25 Sale 138.92 600 83,353 3,252 May 20 11:48 AM Voigtlander Christian B. Chief Operating Officer May 16 '25 Option Exercise 96.83 5,555 537,891 7,944 May 19 05:28 PM Voigtlander Christian B. Chief Operating Officer May 19 '25 Option Exercise 96.83 5,555 537,891 7,944 May 19 05:28 PM Voigtlander Christian B. Chief Operating Officer May 16 '25 Sale 140.00 5,555 777,700 2,389 May 19 05:28 PM Voigtlander Christian B. Chief Operating Officer May 19 '25 Sale 138.00 5,555 766,614 2,389 May 19 05:28 PM FINNEY ELISHA W Director May 19 '25 Proposed Sale 138.92 600 83,353 May 19 04:21 PM Voigtlander Christian B. Chief Operating Officer May 14 '25 Option Exercise 96.83 5,556 537,987 7,945 May 15 04:57 PM Voigtlander Christian B. Chief Operating Officer May 15 '25 Option Exercise 96.83 5,555 537,891 7,944 May 15 04:57 PM Voigtlander Christian B. Chief Operating Officer May 14 '25 Sale 138.65 5,556 770,324 2,389 May 15 04:57 PM Voigtlander Christian B. Chief Operating Officer May 15 '25 Sale 135.55 5,555 752,977 2,389 May 15 04:57 PM Sousa Ben Chief Information Officer May 15 '25 Sale 137.36 2,000 274,714 479 May 15 04:55 PM Sousa Ben Officer May 15 '25 Proposed Sale 137.36 2,000 274,714 May 15 04:27 PM Voigtlander Christian B. Officer May 14 '25 Proposed Sale 138.65 55,556 7,702,684 May 14 02:52 PM FINNEY ELISHA W Director May 13 '25 Option Exercise 0.00 1,723 0 3,852 May 14 11:02 AM KENNEDY KOLLEEN T Director May 13 '25 Option Exercise 0.00 1,723 0 3,285 May 13 08:03 PM Hoffmeister David F Director May 13 '25 Option Exercise 0.00 1,723 0 4,750 May 13 08:03 PM Abbey Donald Director May 13 '25 Option Exercise 0.00 1,723 0 4,750 May 13 08:02 PM Hernandez Laurie Director May 13 '25 Option Exercise 0.00 1,723 0 3,608 May 13 07:42 PM Greenberg David C. Director May 13 '25 Option Exercise 50.17 3,665 183,869 8,702 May 13 07:37 PM Greenberg David C. Director May 13 '25 Sale 143.66 1,942 278,992 6,760 May 13 07:37 PM Greenberg David C. Director May 13 '25 Proposed Sale 143.66 1,942 278,992 May 13 07:01 PM Bonnell Brian Michael Chief Financial Officer Mar 15 '25 Option Exercise 0.00 3,248 0 30,348 Mar 17 08:16 PM Jain Vivek Chairman and CEO Mar 15 '25 Option Exercise 0.00 4,872 0 110,908 Mar 17 08:14 PM Sanzone Virginia Ruth VP, General Counsel Mar 15 '25 Option Exercise 0.00 1,624 0 7,984 Mar 17 08:12 PM Sousa Ben Chief Information Officer Mar 15 '25 Option Exercise 0.00 1,299 0 3,195 Mar 17 08:09 PM Voigtlander Christian B. Chief Operating Officer Mar 15 '25 Option Exercise 0.00 3,248 0 4,181 Mar 17 08:06 PM Woolson Daniel VP, GM-Infusion Capital Mar 15 '25 Option Exercise 0.00 2,923 0 15,488 Mar 17 08:04 PM Sanzone Virginia Ruth VP, General Counsel Mar 08 '25 Option Exercise 0.00 3,189 0 8,119 Mar 10 08:17 PM Sanzone Virginia Ruth VP, General Counsel Mar 07 '25 Option Exercise 0.00 1,073 0 5,555 Mar 10 08:17 PM Jain Vivek Chairman and CEO Mar 07 '25 Option Exercise 0.00 3,218 0 106,036 Mar 10 08:05 PM Sousa Ben Chief Information Officer Mar 08 '25 Option Exercise 0.00 957 0 2,446 Mar 10 07:57 PM Sousa Ben Chief Information Officer Mar 07 '25 Option Exercise 0.00 430 0 1,749 Mar 10 07:57 PM Woolson Daniel VP, GM-Infusion Capital Mar 08 '25 Option Exercise 0.00 2,153 0 13,518 Mar 10 07:52 PM Woolson Daniel VP, GM-Infusion Capital Mar 07 '25 Option Exercise 0.00 966 0 11,832 Mar 10 07:52 PM Voigtlander Christian B. Chief Operating Officer Mar 07 '25 Option Exercise 0.00 2,146 0 2,146 Mar 10 07:38 PM Bonnell Brian Michael Chief Financial Officer Mar 07 '25 Option Exercise 0.00 2,146 0 27,100 Mar 10 07:35 PM Jain Vivek Chairman and CEO Jan 02 '25 Option Exercise 88.76 1,373 121,867 105,966 Jan 02 05:59 PM Jain Vivek Chairman and CEO Jan 02 '25 Sale 155.48 1,373 213,474 104,593 Jan 02 05:59 PM VIVEK JAIN Officer Jan 02 '25 Proposed Sale 155.48 1,373 213,474 Jan 02 04:06 PM Woolson Daniel Officer Dec 06 '24 Proposed Sale 156.25 2,241 350,158 Dec 06 05:22 PM Woolson Daniel VP, GM-Infusion Capital Dec 06 '24 Sale 156.25 2,241 350,158 10,866 Dec 06 04:43 PM Jain Vivek Chairman and CEO Dec 02 '24 Option Exercise 88.76 12,000 1,065,120 116,593 Dec 02 09:12 PM Jain Vivek Chairman and CEO Dec 02 '24 Sale 162.91 12,000 1,954,935 104,593 Dec 02 09:12 PM VIVEK JAIN Officer Dec 02 '24 Proposed Sale 162.91 12,000 1,954,933 Dec 02 04:10 PM Greenberg David C. Director Nov 27 '24 Option Exercise 94.68 972 92,029 6,009 Nov 27 05:36 PM Greenberg David C. Director Nov 27 '24 Sale 158.11 972 153,683 5,037 Nov 27 05:36 PM Voigtlander Christian B. Chief Operating Officer Nov 27 '24 Option Exercise 96.83 1,430 138,467 1,430 Nov 27 05:26 PM Voigtlander Christian B. Chief Operating Officer Nov 27 '24 Sale 158.00 1,430 225,936 0 Nov 27 05:26 PM Greenberg David C. Director Nov 27 '24 Proposed Sale 158.11 972 153,683 Nov 27 04:18 PM Voigtlander Christian B. Chief Operating Officer Nov 26 '24 Option Exercise 96.83 7,719 747,431 7,719 Nov 26 06:20 PM Voigtlander Christian B. Chief Operating Officer Nov 25 '24 Option Exercise 96.83 1,962 189,980 1,962 Nov 26 06:20 PM Voigtlander Christian B. Chief Operating Officer Nov 26 '24 Sale 159.11 7,719 1,228,191 0 Nov 26 06:20 PM Voigtlander Christian B. Chief Operating Officer Nov 25 '24 Sale 169.08 1,962 331,726 0 Nov 26 06:20 PM Voigtlander Christian B. Officer Nov 25 '24 Proposed Sale 171.00 11,111 1,899,981 Nov 25 05:27 PM Jain Vivek Chairman and CEO Nov 01 '24 Option Exercise 88.76 12,000 1,065,120 116,593 Nov 04 07:32 PM Jain Vivek Chairman and CEO Nov 01 '24 Sale 171.84 12,000 2,062,136 104,593 Nov 04 07:32 PM VIVEK JAIN Officer Nov 01 '24 Proposed Sale 171.84 12,000 2,062,135 Nov 01 04:47 PM Jain Vivek Chairman and CEO Oct 01 '24 Option Exercise 88.76 12,000 1,065,120 116,593 Oct 01 05:16 PM Jain Vivek Chairman and CEO Oct 01 '24 Sale 178.46 12,000 2,141,580 104,593 Oct 01 05:16 PM VIVEK JAIN Officer Oct 01 '24 Proposed Sale 178.46 12,000 2,141,579 Oct 01 04:23 PM Jain Vivek Chairman and CEO Sep 03 '24 Option Exercise 88.76 12,000 1,065,120 109,033 Sep 03 06:05 PM Jain Vivek Chairman and CEO Sep 03 '24 Sale 163.46 12,000 1,961,540 104,593 Sep 03 06:05 PM VIVEK JAIN Officer Sep 03 '24 Proposed Sale 163.46 12,000 1,961,539 Sep 03 04:27 PM Woolson Daniel VP, GM-Infusion Capital Aug 30 '24 Sale 163.22 2,502 408,370 13,107 Aug 30 05:26 PM Woolson Daniel Officer Aug 30 '24 Proposed Sale 163.99 2,502 410,303 Aug 30 05:10 PM Jain Vivek Chairman and CEO Aug 16 '24 Option Exercise 88.76 12,000 1,065,120 116,593 Aug 16 05:22 PM Jain Vivek Chairman and CEO Aug 16 '24 Sale 156.04 12,000 1,872,480 104,593 Aug 16 05:22 PM VIVEK JAIN Officer Aug 16 '24 Proposed Sale 156.04 12,000 1,872,480 Aug 16 04:36 PM Smiths Group International Hol Other Aug 13 '24 Proposed Sale 143.90 415,771 59,829,447 Aug 13 04:09 PM Sanzone Virginia Ruth VP, General Counsel Aug 08 '24 Sale 144.11 2,050 295,426 4,482 Aug 08 04:56 PM VIRGINIA SANZONE Officer Aug 08 '24 Proposed Sale 144.11 2,050 295,426 Aug 08 04:11 PM Voigtlander Christian B. Chief Operating Officer May 30 '24 Sale 103.95 12,539 1,303,485 0 May 30 06:03 PM